Expanded safety analysis of pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, in patients with acute myeloid leukemia and myelodysplastic syndromes.

Published online

Journal Article

Full Text

Duke Authors

Erba, Harry Paul

Cited Authors

Swords, RT; Watts, J; Erba, HP; Altman, JK; Maris, M; Anwer, F; Hua, Z; Stein, H; Faessel, H; Sedarati, F; Dezube, BJ; Giles, FJ; Medeiros, BC; DeAngelo, DJ

Published Date

February 3, 2017

Published In

Blood Cancer Journal

Volume / Issue

7 / 2

Start / End Page

e520 -

PubMed ID

28157218

Pubmed Central ID

28157218

Electronic International Standard Serial Number (EISSN)

2044-5385

Digital Object Identifier (DOI)

10.1038/bcj.2017.1

Language

eng

Conference Location

United States